“…To date, cardiac optical mapping, also known as optocardiography (Boukens and Efimov, 2014;George and Efimov, 2019;Swift et al, 2019), has been used to investigate changes in electrical activity, spiral wave formation (Jalife, 2003), excitation-contraction coupling (Christoph et al, 2017), sarcoplasmic reticulum-specific calcium cycling (Wang et al, 2014), metabolic status (Mercader et al, 2012;Wengrowski et al, 2014;Kuzmiak-Glancy et al, 2015;Jaimes et al, 2016a;Garrott et al, 2017), the efficacy of ablation therapies (Swift et al, 2014), stem-cell engraftment (Costa et al, 2012;Shiba et al, 2012;Filice et al, 2020), cardiotoxicity (Jaimes et al, 2019b), and the pathobiology of heart failure (Spragg and Kass, 2006; Abbreviations: APD 80 , action potential duration at 80% repolarization; AUF, arbitrary units of fluorescence; Ca 2+ , intracellular calcium; CaD 80 , calcium transient duration at 80% reuptake; dF/F0, change in fluorescence over baseline; hiPSC-CM, human induced pluripotent stem cell-derived cardiomyocytes; PCL, pacing cycle length; SNR, signal-to-noise ratio; V m , transmembrane voltage. Ng et al, 2014;Zasadny et al, 2020).…”